Page last updated: 2024-10-27

flumazenil and Age-Related Macular Degeneration

flumazenil has been researched along with Age-Related Macular Degeneration in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Acar, N1
Merle, BMJ1
Ajana, S1
He, Z1
Grégoire, S1
Hejblum, BP1
Martine, L1
Buaud, B1
Bron, AM1
Creuzot-Garcher, CP1
Korobelnik, JF1
Berdeaux, O1
Jacqmin-Gadda, H1
Bretillon, L1
Delcourt, C1

Other Studies

1 other study available for flumazenil and Age-Related Macular Degeneration

ArticleYear
Predicting the retinal content in omega-3 fatty acids for age-related macular-degeneration.
    Clinical and translational medicine, 2021, Volume: 11, Issue:7

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Cholesterol Esters; Dietary Supplements; Discriminant

2021